Save
Email
Print
Share
RSSBrowse News Stories
151 to 160 of 657 stories
view headlines only
-
Entry Inhibitors Show Promise as Drugs With New MOA for Treatment of HBV and HDV Infection
April 2, 2011 — Promising new viral hepatitis data show that entry inhibitors a new mechanism of action for drugs to treat viral hepatitis could provide the first new hepatitis B and hepatitis D treatments for many ... > full story -
New Data Show Non-Alcoholic Fatty Liver Disease Will Reach Epidemic Status in the US
April 2, 2011 — According to new data the United States could soon be faced with an epidemic of non-alcoholic fatty liver disease, one of the major contributing factors of chronic liver disease, considered as one of ... > full story -
Liver Disease
Personalized Medicine
Today's Healthcare
Wounds and Healing
Diseases and Conditions
Viruses
The Future Looks Bright for HCV Patients Who Have Failed to Respond to Current Treatments
April 1, 2011 — Highly anticipated data from a number of clinical trials have confirmed that a range of new proteases inhibitors will help treat patients who have previously failed therapy for the treatment of ... > full story -
New Studies Provide Beneficial Insights Expanding the Pool of Liver Grafts and Transplants
April 1, 2011 — Findings from two new studies confirm that there are options for clinicians to expand the pool of liver grafts for use in patients with liver ... > full story -
Liver Disease
Today's Healthcare
Chronic Illness
Wounds and Healing
Diseases and Conditions
Health Policy
First Study in Decade Provides Hope for Patients Suffering from Primary Biliary Cirrhosis
March 31, 2011 — Results from a new study suggest that obeticholic acid is a safe and effective treatment for patients suffering from primary biliary cirrhosis (PBC) as demonstrated by substantial decreases in the ... > full story -
Sequential Treatment With Entecavir and Lamivudine Results in Rebound of Hepatitis B Virus, Study Suggests
March 31, 2011 — A two-year trial of entecavir followed by lamivudine in patients with chronic hepatitis B virus (HBV) infection resulted in a virologic rebound rate of 24 percent and 12 percent drug-resistance rate. ... > full story -
Benefits of D-Penicillamine and Trientine for Wilson Disease Confirmed, According to New Study
March 31, 2011 — Results from a new study have shown both D-penicillamine and trientine continue to be effective treatments, providing positive survival rates in patients with Wilson disease free from a liver ... > full story -
Liver Disease
Kidney Disease
Today's Healthcare
Wounds and Healing
Diseases and Conditions
Multiple Sclerosis Research
Results Show Benefits in Using Acute Kidney Injury Criteria in the Diagnosis of Cirrhosis
March 31, 2011 — The first clinical study investigating the use of the AKIN criteria (Acute Kidney Injury Network) in cirrhosis has shown significant benefits that have the potential to change future diagnosis, ... > full story -
Cholesterol Regulator Plays Key Role in Development of Liver Scarring, Cirrhosis
March 30, 2011 — Researchers have demonstrated that a key regulator of cholesterol and fat metabolism in the liver also plays an important role in the development of liver fibrosis -- the build-up of collagen scar ... > full story -
Hepatitis C Drug May Revolutionize Treatment
March 30, 2011 — The drug boceprevir helps cure hard-to-treat hepatitis C, offering a brighter outlook for patients who have not responded to standard ... > full story
Search ScienceDaily
Number of stories in archives: 137,075
more 
